Filing Details
- Accession Number:
- 0001127602-18-023857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-25 18:45:40
- Reporting Period:
- 2018-07-24
- Accepted Time:
- 2018-07-25 18:45:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1507332 | Davide Molho | 251 Ballardvale Street Wilmington MA 01887 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-24 | 5,474 | $59.41 | 27,553 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-07-24 | 8,375 | $73.70 | 35,928 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-24 | 18,773 | $125.00 | 17,155 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-07-24 | 5,474 | $0.00 | 5,474 | $59.41 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-07-24 | 8,375 | $0.00 | 8,375 | $73.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-28 | 2021-02-28 | No | 4 | M | Direct |
| 16,749 | 2017-02-26 | 2021-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 40,748 | Indirect | By Revocable Trust |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
